Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Dysplasia 1Triple Negative Breast Neoplasms 1Rectal Neoplasms 1Neoplasm Metastasis 1Colonic Neoplasms 1Carcinoma 1

Interventions

Imiquimod 2Flow Cytometry 2Colposcopy 2Biopsy 2motexafin lutetium 1Zoledronic Acid 1Surveys and Questionnaires 1Spectrometry, Fluorescence 1Sodium Chloride 1Quantitative Phase Imaging 1Photochemotherapy 1Omeprazole 1Mutagenesis, Insertional 1Multimodal Imaging 1Microarray Analysis 1Indomethacin 1Immunohistochemistry 1IRX 2 1Geritol 1Fluorescent Antibody Technique 1Cyclophosphamide 1Cryosurgery 1Conization 15-aminolevulinic acid hexyl ester 11-phenyl-3,3-dimethyltriazene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Uterine Cervical Dysplasia × Indomethacin × Clear all
NCT03267680 2025-04-13

IRX-2 Regimen in Treating Women With Cervical Squamous Intraepithelial Neoplasia 3 or Squamous Vulvar Intraepithelial Neoplasia 3

University of Southern California

Phase 2 Terminated
10 enrolled 19 charts
Gynecologic

Uterine Cervical Dysplasia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡